Xevirol 5 MG (Everolimus)

Note: Everolimus is also used, at much lower doses and under different brand names, to prevent organ transplant rejection. This page describes the oncology use of Everolimus at the 5mg strength; please confirm Xevirol’s intended indication matches the oncology dosing described below before publishing.

Basic Product Information of Xevirol (Everolimus) 5mg

How Xevirol (Everolimus) Works

Xevirol contains Everolimus, a derivative of rapamycin that selectively inhibits mTOR (mammalian target of rapamycin), a central signalling enzyme that regulates cell growth, proliferation, protein synthesis, and metabolism. Everolimus binds with high affinity to the intracellular protein FKBP-12, and this complex then inhibits mTOR complex 1 (mTORC1) activity.

In many cancers, the PI3K/AKT/mTOR pathway is overactive, driving uncontrolled tumour cell growth. By inhibiting mTORC1, Xevirol slows tumour cell proliferation directly and also reduces angiogenesis, the formation of new blood vessels that supply tumours, by lowering HIF-1 activity and VEGF production. In tuberous sclerosis complex, where mTOR signalling is chronically overactive due to genetic mutations, this same mechanism helps shrink SEGA brain tumours and kidney angiomyolipomas.

Xevirol is a once-daily oral tablet, usually taken consistently either always with or always without food, and is often combined with other anticancer or endocrine therapies depending on the indication.

Indications for Xevirol (Everolimus)

Xevirol (Everolimus) is indicated for the following conditions:

Benefits of Xevirol (Everolimus) 5mg

How to Take Xevirol (Everolimus)

Monitoring and Dosage Adjustments

Regular monitoring is essential during Xevirol treatment. Your healthcare provider will monitor blood glucose and lipid levels, given the risk of hyperglycaemia and elevated cholesterol/triglycerides, renal function, and complete blood counts for anaemia, low white cells, or low platelets. Monitoring also includes watchfulness for respiratory symptoms that could indicate non-infectious pneumonitis, mouth sores (stomatitis), which are very common and can be dose-limiting, and signs of infection, given Everolimus’s immunosuppressive effects. Report any new cough, breathlessness, fever, or mouth pain to your doctor promptly.

Drug Interactions and Important Information

Everolimus is metabolised primarily by CYP3A4 and is a substrate of P-glycoprotein. Avoid strong CYP3A4 inhibitors such as ketoconazole, itraconazole, clarithromycin, and ritonavir, and grapefruit or grapefruit juice, as these can significantly increase Everolimus levels. Avoid strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin, and St. John’s Wort, as these can substantially reduce efficacy.

Concomitant use with ACE inhibitors may increase the risk of angioedema. Live vaccines should be avoided during treatment. Always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Xevirol.

Side Effects and Precautions

Who Should Use Xevirol (Everolimus)?

Xevirol is suitable for postmenopausal women with advanced HR-positive, HER2-negative breast cancer, adult patients with progressive neuroendocrine tumours of pancreatic, GI, or lung origin, adults with advanced renal cell carcinoma after prior VEGF-targeted therapy, and adult or eligible paediatric patients with SEGA or renal angiomyolipoma related to tuberous sclerosis complex. It is prescribed by oncologists, urologists, and specialist physicians experienced in managing these conditions. Baseline blood counts, renal function, blood glucose, and lipid levels should be assessed before starting treatment.

Manufacturer

Xevirol (Everolimus) is manufactured in Bangladesh under strict WHO-GMP, cGMP, and ISO-certified standards, offering an affordable and bioequivalent alternative to Afinitor by Novartis at a fraction of the cost. [Please confirm the exact manufacturer name so it can be added here and in the specs table above.]

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty oncology medications. We ensure Xevirol (Everolimus) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Xevirol (Everolimus) from Mediaid Pharmacy?

Xevirol represents an important, versatile targeted therapy option across several difficult-to-treat tumour types. As the generic equivalent of Afinitor by Novartis, it delivers the same active ingredient, Everolimus, with the same proven mTOR inhibition mechanism at a dramatically more affordable price. Manufactured under WHO-GMP and cGMP standards and distributed globally by Mediaid Pharmacy, Xevirol gives patients worldwide access to high-quality targeted oncology therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Everolimus option with worldwide delivery, Xevirol from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Xevirol (Everolimus)